Skip to main content

December 2017

 

 

academics

 

Clinical research courses

Vacancy for Assistant and Associate professor at Monad university school of pharmacy

Monad university school of pharmacy ,welcome you to the mesmerizing world of pharmacy ,a placed infused with quality and ethics in pharma education.

Post : Assistant and Associate professor

Applications are invited for Junior Research Fellow /Senior Research Fellow at Assam University

Assam University came into existence through Assam (Central) University Act, 1989 . It was  established in 1994,since then  the University is steadily becoming  an excellent centre of learning.  The campus, situated in Dargakona, about 20 kms from  Silchar, is set amid sprawling hillocks, a typical landscape in the  North East. The campus  in an area of  600 acres surrounded by lakes and mountains provides  an ideal environment for academic pursuit.   Drawing its 230 plus faculty from many disciplines, from all over the country, the university sustains a multidisciplinary approach to higher education.

Applications are invited for the recruitment of one Junior Research Fellow (JRF)/Senior Research Fellow (SRF) position to work in a DBT funded project entitled “Functional genomics for drought tolerance in Assam Rice” for a period of three years.

Require Zonal Manager at Merck Limited | B.Pharm, B.Sc MBA

Merck Limited was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post : Zonal Manager

Job for B.Pharm as Executive at Merck Limited

Merck Limited was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post : Executive

Vacancy for Senior Pharmacovigilance Leader in Novartis

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Senior Pharmacovigilance Leader

Require Principal at Padmavathi College of Pharmacy & Research Institute

PADMAVATHI COLLEGE OF PHARMACY & RESEARCH INSTITUTE,Dharmapuri is a unique and premier institute in Tamilnaidu.its is a Self financing institute managed by Sri Govinda Gounder Memorial Educational Trust,Dharmapuri. The institute was established in 1992 by the chairman,Mr.M.G.SEKHAR,BA.,B.L

Post : Principal

Job in Production at Micro Labs | walk in

Micro Labs, one of the fastest growing pharmaceutical companies in India with Global operations in over 60 countries. We enjoy a strong presence in various segments like Cardiology, Opthalmology, Psychiatry, Dermatology, Diabetology etc. with most of its brands among TOP 5 in their respective category.

Walk in at IICB for the post of Junior Research Fellow | 40 posts

IICB Institute was established in 1935 as the first non official centre in India for biomedical research and was included within the aegis of CSIR in 1956.
IICB today is engaged in research on diseases of national importance and biological problems of global interest, employing sophisticated state-of-the-art technology in keeping with the rapid and unprecedented momentum that life science research has gained globally over the last 50 years.
IICB is one of the major institutes in India which initiated, right from its inception, multidisciplinary concerted efforts for conducting basic research on infectious diseases, specifically leishmaniasis and cholera, along with the development of technologies for the diagnosis, immunoprophylaxis, and chemotherapy of the diseases.

Advertisement No.: R&C/JRF/501/2017

Vacancy Code: 5011701

Position: Junior Research Fellow

Walk in Interview for Lm Bioassay, Hybridoma, Protein Expression & Protein Purification at Syngene International

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities. The state-of-the-art research facilities have been qualified by various pharmaceutical majors & regulatory agencies and has received various certifications including ISO 9001: 2008, ISO 14001:2004, OHSAS 18001:2007, GLP and AAALAC.

Vedanta Biosciences, an affiliate of PureTech Health developing a new category of therapies for immune-mediated and infectious diseases based on rationally defined consortium of human microbiome-derived bacteria, announced that the United States Patent and Trademark Office (USPTO) has issued four new patents, US 9,801,933, US 9,808,519, US 9,827,276, and US 9,833,483. The new patents broadly cover pharmaceutical compositions including Clostridium bacterial strains and methods of use for therapeutic products, including consortia of bacterial strains and spore-forming fractions based on beneficial bacteria. The newly issued patents are exclusively licensed to Vedanta under an agreement with the University of Tokyo and provide coverage through at least 2031. These issuances further strengthen Vedanta’s leading intellectual property position in the microbiome field, which includes previous issuances US 9,415,079, US 9,421,230, US 9,433,652, US 9,642,882, US 9,662,381, EP2575835, JP5592958, JP5853063, and JP6115971.